$3.42
0.051.48%
Ultimo aggiornamento: Nov 21, 9:42 AM
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Larimar Therapeutics Inc (NASDAQ:LRMR) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 8.82M a 9.10M. Questo rappresenta il 15.99% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 1.51M azioni scambiate al giorno, ci vorrebbero 6.02 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
9.10M
Vendite allo scoperto %
16.0%
Giorni di copertura
6.02
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
LRMR | Larimar Therapeutics, Inc. Com | 10/31/2025 | 11/11/2025 | 15.99% | 56,935,826 | 9,103,944 | 1,511,713 | 6.02 | |
LRMR | Larimar Therapeutics, Inc. Com | 10/15/2025 | 10/24/2025 | 15.49% | 56,935,826 | 8,816,753 | 4,233,686 | 2.08 | |
LRMR | Larimar Therapeutics, Inc. Com | 09/30/2025 | 10/09/2025 | 15.71% | 56,935,826 | 8,944,347 | 4,969,145 | 1.8 | |
LRMR | Larimar Therapeutics, Inc. Com | 09/15/2025 | 09/24/2025 | 13.44% | 56,935,826 | 7,653,965 | 1,316,152 | 5.82 | |
LRMR | Larimar Therapeutics, Inc. Com | 08/29/2025 | 09/10/2025 | 11.25% | 56,935,826 | 6,402,490 | 1,266,950 | 5.05 | |
LRMR | Larimar Therapeutics, Inc. Com | 08/15/2025 | 08/26/2025 | 10.35% | 56,935,826 | 5,894,329 | 2,030,219 | 2.9 | |
LRMR | Larimar Therapeutics, Inc. Com | 07/31/2025 | 08/11/2025 | 11.18% | 56,935,826 | 6,365,303 | 1,279,043 | 4.98 | |
LRMR | Larimar Therapeutics, Inc. Com | 07/15/2025 | 07/24/2025 | 17.37% | 35,373,326 | 6,145,819 | 771,269 | 7.97 | |
LRMR | Larimar Therapeutics, Inc. Com | 06/30/2025 | 07/10/2025 | 17.70% | 35,373,326 | 6,262,837 | 1,497,608 | 4.18 | |
LRMR | Larimar Therapeutics, Inc. Com | 06/13/2025 | 06/25/2025 | 18.36% | 35,373,326 | 6,493,245 | 1,308,034 | 4.96 | |
LRMR | Larimar Therapeutics, Inc. Com | 05/30/2025 | 06/10/2025 | 18.02% | 35,373,326 | 6,373,469 | 1,114,815 | 5.72 | |
LRMR | Larimar Therapeutics, Inc. Com | 05/15/2025 | 05/27/2025 | 27.80% | 35,373,326 | 9,832,396 | 1,610,713 | 6.1 | |
LRMR | Larimar Therapeutics, Inc. Com | 04/30/2025 | 05/09/2025 | 16.87% | 35,373,326 | 5,968,450 | 1,261,231 | 4.73 | |
LRMR | Larimar Therapeutics, Inc. Com | 04/15/2025 | 04/25/2025 | 15.92% | 35,373,326 | 5,632,494 | 863,761 | 6.52 | |
LRMR | Larimar Therapeutics, Inc. Com | 03/31/2025 | 04/09/2025 | 11.50% | 41,893,112 | 4,816,732 | 1,179,676 | 4.08 | |
LRMR | Larimar Therapeutics, Inc. Com | 03/14/2025 | 03/25/2025 | 12.18% | 41,671,848 | 5,077,276 | 583,686 | 8.7 | |
LRMR | Larimar Therapeutics, Inc. Com | 02/28/2025 | 03/11/2025 | 12.21% | 41,671,848 | 5,089,276 | 501,479 | 10.15 | |
LRMR | Larimar Therapeutics, Inc. Com | 02/14/2025 | 02/26/2025 | 12.90% | 41,671,848 | 5,375,685 | 610,797 | 8.8 | |
LRMR | Larimar Therapeutics, Inc. Com | 01/31/2025 | 02/11/2025 | 12.17% | 41,671,848 | 5,070,734 | 570,238 | 8.89 | |
LRMR | Larimar Therapeutics, Inc. Com | 01/15/2025 | 01/27/2025 | 12.57% | 41,671,848 | 5,240,154 | 491,419 | 10.66 | |
LRMR | Larimar Therapeutics, Inc. Com | 12/31/2024 | 01/10/2025 | 12.17% | 41,671,848 | 5,070,190 | 1,493,273 | 3.4 | |
LRMR | Larimar Therapeutics, Inc. Com | 12/13/2024 | 12/24/2024 | 10.73% | 41,671,848 | 4,470,190 | 691,082 | 6.47 | |
LRMR | Larimar Therapeutics, Inc. Com | 11/29/2024 | 12/10/2024 | 9.31% | 41,671,848 | 3,877,818 | 666,574 | 5.82 | |
LRMR | Larimar Therapeutics, Inc. Com | 11/15/2024 | 11/26/2024 | 7.93% | 41,671,848 | 3,306,659 | 858,824 | 3.85 | |
LRMR | Larimar Therapeutics, Inc. Com | 10/31/2024 | 11/11/2024 | 6.54% | 41,671,848 | 2,724,458 | 646,254 | 4.22 | |
LRMR | Larimar Therapeutics, Inc. Com | 10/15/2024 | 10/24/2024 | 8.91% | 41,671,848 | 3,712,928 | 695,510 | 5.34 | |
LRMR | Larimar Therapeutics, Inc. Com | 09/30/2024 | 10/09/2024 | 8.57% | 41,671,848 | 3,570,849 | 913,744 | 3.91 | |
LRMR | Larimar Therapeutics, Inc. Com | 09/13/2024 | 09/24/2024 | 7.98% | 41,671,848 | 3,325,594 | 633,881 | 5.25 | |
LRMR | Larimar Therapeutics, Inc. Com | 08/30/2024 | 09/11/2024 | 8.32% | 41,671,848 | 3,467,705 | 226,967 | 15.28 | |
LRMR | Larimar Therapeutics, Inc. Com | 07/31/2024 | 08/09/2024 | 8.36% | 41,667,237 | 3,483,960 | 388,236 | 8.97 | |
LRMR | Larimar Therapeutics, Inc. Com | 07/15/2024 | 07/24/2024 | 8.70% | 41,667,237 | 3,625,213 | 607,559 | 5.97 | |
LRMR | Larimar Therapeutics, Inc. Com | 06/28/2024 | 07/10/2024 | 6.92% | 41,667,237 | 2,882,072 | 986,099 | 2.92 | |
LRMR | Larimar Therapeutics, Inc. Com | 06/14/2024 | 06/26/2024 | 7.84% | 41,667,237 | 3,268,401 | 529,974 | 6.17 | |
LRMR | Larimar Therapeutics, Inc. Com | 05/31/2024 | 06/11/2024 | 7.72% | 41,667,237 | 3,218,387 | 780,174 | 4.13 | |
LRMR | Larimar Therapeutics, Inc. Com | 05/15/2024 | 05/24/2024 | 9.38% | 41,667,237 | 3,907,737 | 251,244 | 15.55 | |
LRMR | Larimar Therapeutics, Inc. Com | 04/30/2024 | 05/09/2024 | 9.37% | 41,667,237 | 3,904,992 | 306,038 | 12.76 | |
LRMR | Larimar Therapeutics, Inc. Com | 04/15/2024 | 04/24/2024 | 8.72% | 41,665,237 | 3,632,096 | 375,110 | 9.68 | |
LRMR | Larimar Therapeutics, Inc. Com | 03/28/2024 | 04/09/2024 | 6.96% | 45,891,809 | 3,191,918 | 579,342 | 5.51 | |
LRMR | Larimar Therapeutics, Inc. Com | 03/15/2024 | 03/26/2024 | 3.55% | 45,891,809 | 1,629,787 | 572,049 | 2.85 | |
LRMR | Larimar Therapeutics, Inc. Com | 02/29/2024 | 03/11/2024 | 1.11% | 45,737,703 | 506,814 | 621,547 | 1 | |
LRMR | Larimar Therapeutics, Inc. Com | 02/15/2024 | 02/27/2024 | 1.35% | 45,734,537 | 618,199 | 1,377,568 | 1 | |
LRMR | Larimar Therapeutics, Inc. Com | 01/31/2024 | 02/09/2024 | 1.31% | 25,997,695 | 339,698 | 151,863 | 2.24 | |
LRMR | Larimar Therapeutics, Inc. Com | 01/12/2024 | 01/24/2024 | 1.37% | 25,997,695 | 357,114 | 306,502 | 1.17 | |
LRMR | Larimar Therapeutics, Inc. Com | 12/29/2023 | 01/10/2024 | 1.50% | 25,997,695 | 390,013 | 97,921 | 3.98 | |
LRMR | Larimar Therapeutics, Inc. Com | 12/15/2023 | 12/27/2023 | 1.56% | 25,997,695 | 406,122 | 93,233 | 4.36 | |
LRMR | Larimar Therapeutics, Inc. Com | 11/30/2023 | 12/11/2023 | 1.87% | 25,997,695 | 486,376 | 102,971 | 4.72 | |
LRMR | Larimar Therapeutics, Inc. Com | 11/15/2023 | 11/27/2023 | 2.03% | 25,997,695 | 527,370 | 100,545 | 5.25 |
In cerca di azioni più vendute allo scoperto?